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Benchmarking of copper(II) LFMM parameters for studying amyloid-β peptides
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Ligand ﬁeld molecular mechanics (LFMM) parameters have been benchmarked for copper (II) bound to the
amyloid-β1–16 peptide fragment. Several density functional theory (DFT) optimised small test models, representative of
different possible copper coordination modes, have been used to test the accuracy of the LFMM copper bond lengths
and angles, resulting in errors typically less than 0.1 Å and 5°. Ligand ﬁeld molecular dynamics (LFMD) simulations
have been carried out on the copper bound amyloid-β1–16 peptide and snapshots extracted from the subsequent trajectory.
Snapshots have been optimised using DFT and the semi-empirical PM7 method resulting in good agreement against the
LFMM calculated geometry. Analysis of substructures within snapshots shows that the larger contribution of geometrical
difference, as measured by RMSD, lies within the peptide backbone, arising from differences in DFT and AMBER, and
the copper coordination sphere is reproduced well by LFMM. PM7 performs excellently against LFMM with an average
RMSD of 0.2 Å over 21 tested snapshots. Further analysis of the LFMD trajectory shows that copper bond lengths and
angles have only small deviations from average values, with the exception of a carbonyl moiety from the N-terminus,
which can act as a weakly bound ﬁfth ligand.
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Introduction
Alzheimer’s disease is one of the major health challenges
facing modern society. Its etiology is complex but the
importance of amyloid-β (Aβ) peptide in this has long
been reported, (Masters et al., 1985) with aggregation of
Aβ ﬁbrils and plaques observed in the brains of
Alzheimer’s patients. The N-terminus of Aβ contains
several residues that can act as ligands towards transition
metals, (Bolognin et al., 2011; Kowalik-Jankowska,
Ruta-Dolejsz, Wisniewska, & Lankiewicz, 2001; Zirah
et al., 2006) such that the structural and/or chemical
effects of metal coordination have been proposed to play
a role in the onset of Alzheimer’s (Bush, 2003; Spinello,
Bonsignore, Barone, Keppler, & Terenzi, 2016). Natu-
rally occurring metals in the brain include copper, iron
and zinc, the redox activity of the former two indicating
a possible mechanism for damage to brain cells (Huang
et al., 1999; Jomova, Vondrakova, Lawson, & Valko,
2010). Moreover, non-natural metals such as platinum
show promise as potential anti-Alzheimer’s agents
through disruption of native metal coordination
(Barnham et al., 2008; Turner, Platts, & Deeth, 2016).
A large body of experimental work has shed light on
copper–Aβ coordination, (Kepp, 2012; Warmlander
et al., 2013) supplemented by extensive simulation work
(Ali-Torres, Mirats, Marechal, Rodriguez-Santiago, &
Sodupe, 2015). Classical molecular dynamics (MD)
simulations have been a powerful computational tool in
elucidating structural information of copper–Aβ com-
plexes. Raffa and Rauk (2007) used DFT benchmarks to
include copper parameters in the Gromacs force ﬁeld for
simulations of Aβ1–42 monomers to study how binding
perturbed the peptide secondary structure. Similar
approaches were carried out by Dong et al. (2016) and
Kozman and Tvaroska (2015) focusing on aggregation
inhibition by small molecule drugs and curcumin, respec-
tively. Huy, Vuong, La Penna, Faller, and Li (2016)
recently used microsecond MD simulations to model the
structure and dynamics of Cu–Aβ1–42 dimer interactions.
Despite this extensive work there is still contention over
which residues are actively involved in binding copper at
physiological conditions. Reports acknowledge the
importance of histidine as nitrogen ligands but several
potential oxygen ligands have been reported, including
those within alanine, aspartic acid, glutamic acid and tyr-
osine residues (Dorlet, Gambarelli, Faller, & Hureau,
2009; Drew, Masters, & Barnham, 2009; Minicozzi
et al., 2008; Streltsov et al., 2008).
DFT and ab initio methods have also been utilised
within studying copper binding sites, but due to compu-
tational expense truncated models are required, such as
Cu–Aβ1–16. This relatively smaller peptide allows for the
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effective use of ab inito MD simulations (Furlan,
Hureau, Faller, & La Penna, 2010; La Penna, Hureau,
Andreussi, & Faller, 2013). Quantum mechanics/molecu-
lar mechanics (QM/MM) have also been utilised on this
system to model energetics and redox potentials of dif-
ferent binding modes (Ali-Torres, Marechal, Rodriguez-
Santiago, & Sodupe, 2011; Ali-Torres, Mirats, Marechal,
Rodriguez-Santiago, & Sodupe, 2014).
Extensive QM/MM studies combined with homology
modelling were carried out by Ali-Torres et al. (2011) to
probe the Cu(II)–Aβ1–16 coordination sphere. The 3N1O
model was considered with His6, His13 and His14 as
nitrogen ligands with both δ and ε binding modes, with
a range of potential residues for the oxygen ligand. A
comparison of implicitly solvated free energy calcula-
tions revealed the most stable complex to contain the
backbone carbonyl oxygen of the ALA2 residue, known
as component II (Drew, Noble, Masters, Hanson, &
Barnham, 2008). This result was also in agreement with
the experimental EPR results of Barnham and co-work-
ers (Drew et al., 2009). These calculations conﬁrmed the
preferential histidine binding modes to be ε, δ and ε for
HIS6, HIS13 and HIS14, respectively. In light of the
above reports the [Oc
A2,Nε
H6,Nδ
H13,Nε
H14] model of Cu
(II)–Aβ1–16 was chosen as the focal point of this study,
as shown in Figure 1.
An alternative to use of ad hoc molecular mechanics
parameters for Cu is ligand ﬁeld molecular mechanics
(LFMM), which captures key d-orbital effects in a small
number of transferable parameters. This approach has
previously been used successfully to study copper-con-
taining transition metal complexes in a variety of sys-
tems, including type 1 copper proteins, (Deeth, 2007)
type 3 copper proteins, (Diedrich & Deeth, 2008) and
bispidine complexes (Bentz et al., 2008). In this work,
we test the suitability of the LFMM approach for
describing Cu(II)–Aβ1–16 coordination, then employ this
approach to carry out molecular dynamics simulations of
this model system.
Computational details
All DFT calculations were carried out using Gaussian09,
(Frisch et al., 2016) whilst semi-empirical calculations
were carried out using MOPAC2012 (Stewart, 2012). All
LFMM calculations were undertaken within the Dommi-
MOE extension (Deeth, Fey, & Williams-Hubbard, 2004)
to the Molecular Operating Environment (MOE) (MOE,
2017). Ligand ﬁeld molecular dynamics (LFMD) simula-
tions were carried out within DL_POLY_LF, (Tai et al.,
2012) which implements LFMM within the DL_POLY
classic molecular dynamics package (Smith, Yong, &
Rodger, 2002).
The Cu(II)–Aβ1–16 system was constructed in MOE.
The N terminus at ASP1 was left uncapped in the zwitte-
rionic form found at physiological pH, whereas the C
terminus at LYS16 was capped with an amide group.
The three histidine residues were built in the neutral
form and all other residues were left as standard charges
at physiological pH, leading to an overall charge of +1.
AMBER parm94 parameters were assigned for the entire
peptide using MOE’s dictionary lookup, then charges
modiﬁed to include the presence of copper using the
scheme of Comba and Remenyi (2002). Altered charges
are reported in Supporting Information (Table S1).
LFMD simulations on Cu(II)–Aβ1–16 were carried out
with the LFMM/AMBER parm94 forceﬁeld at 310 K,
with reaction ﬁeld electrostatics with a van der Waals
cutoff of 10 Å and long range cutoff of 21 Å. A 10 ns
simulation was run in the NVT ensemble, with a 1 fs
integration timestep used throughout.
Benchmarking calculations were carried out with a
variety of hybrid DFT methods, namely M06-2X,
BHandH and B3LYP both with and without Grimme’s
empirical dispersion correction, B3LYP(-D2) (Grimme,
2006). The 6-31G* basis set, combined with LANL2DZ
and associated pseudopotentials for copper was used
throughout. This level of theory was deemed suitable by
Sousa et al. (2013) for studying systems containing cop-
per. Aqueous solvation was accounted for in all DFT cal-
culations with the use of the CPCM polarisable
conductor model. Semi-empirical calculations were car-
ried out using the PM7 method, (Stewart, 2013) with the
COSMO solvation model.
Results and discussion
The similarity of the reported distorted tetrahedral
coordination of Cu(II) by Aβ to that seen in Type I
copper proteins led us to use those reported previously
for the latter as an initial set of LFMM parameters
Figure 1. Graphical representation of Cu(II)–Aβ1–16 with the
[Oc
A2,Nε
H6,Nδ
H13,Nε
H14] copper binding mode.
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(Deeth, 2007). Atomic charges for Cu-coordinated resi-
dues were calculated using Comba’s scheme (Comba &
Remenyi, 2002). Parameters were then reﬁned against
DFT structures of model complexes (vide infra), then
tested for Cu(II)–Aβ1–16 and smaller models representa-
tive of the metal binding within this system.
LFMM parameters were initially tested against DFT
results on six simple four-coordinate copper complexes.
These models are representative of potential binding sites
of copper to Aβ in the manner described above. Imida-
zole (imid) and formamide (form) are used to represent
histidine and carbonyl backbone coordination, respec-
tively. The models include all the potential combinations
of these two ligands. Figure 2 compares these complexes
optimised with LFMM, in yellow, and B3LYP-D2, in
blue. Parameters (r0 and α for Morse potential plus
ligand–ligand repulsion terms) were adjusted in order to
minimise the root mean square deviation (RMSD) of
atomic positions from DFT structures. In general, param-
eters were very close to those previously reported for
Type I copper proteins. New LFMM parameters, in the
MOE format, are reported in supporting information.
All six models in Figure 2 show good agreement
between LFMM and B3LYP-D2 optimised structures,
although minor deviations relating to the orientation of
imidazole ligands are present in B and C. LFMM bond
lengths are typically within 0.1 Å of B3LYP-D2 values,
similar to previous performance reported for LFMM
(Deeth, 2007). Angles around the Cu centre are generally
within 1° on average for pseudo-cis ligands, and within
5° for pseudo-trans ones, with the largest difference of
10° for model B. A very similar pattern of agreement
between DFT and LFMM is found using different func-
tionals: all data are reported in tables S2 and S3 in the
supporting information.
A larger model system representative of the copper
binding site in Aβ, with one alanine and three histidine
ligands, was also used to test LFMM parameters. A
comparison of LFMM (yellow) and B3LYP-D2 (blue)
optimised geometries is shown in Figure 3, which shows
good agreement between the LFMM and B3LYP-D2
optimised structures. Differences in bond lengths of 0.08
and 0.01 Å are found for average Cu–N and Cu–O,
respectively, and 5° and 1° for O–Cu–N and N–Cu–N
angles, respectively. These small differences show that
the LFMM copper parameters model the copper coordi-
nation geometry to a high degree of accuracy against
DFT results.
The generally excellent agreement for truncated
model systems optimised by LFMM and DFT led us to
use the former in MD simulations on the Cu(II)–Aβ1–16
system. The good performance of PM7 might also offer
a means to carry out dynamical simulation, but the extra
speed of the LFMM approach makes it especially attrac-
tive for this purpose. The 16 residue peptide with copper
was constructed in MOE and optimised with LFMM. To
(A) (B)
(C) (D)
(E) (F)
Figure 2. Overlay of test systems optimised with B3LYP-D2/
6-31G*-LANL2DZ (blue) and LFMM (yellow). (A) [Cu
(imid)4]
2+, (B) [Cu(imid)3form]
2+, (C) trans-[Cu(imid)2(-
form)2]
2+, (D) cis-[Cu(imid)2(form)2]
2+, (E) [Cu(form)3imid]
2+
and (F) [Cu(form)4]
2+.
Figure 3. Overlay of truncated binding site model optimised
with B3LYP-D2/6-31G*-LANL2DZ (blue) and LFMM (yel-
low). Copper atoms have been forced to overlap for clarity.
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ﬁnd a suitable starting point for LFMD simulations, con-
formational searching was carried out with low mode
molecular dynamics, (Turner et al., 2016) with the lowest
energy structure from the low mode molecular dynamics
used as the starting point. A plot of RMSD from the
starting point for a 10 ns trajectory is shown in
Figure 4(a). This shows large changes in the initial
2.5 ns of simulation, before reaching a plateau at approx-
imately 1.9 Å for the bulk of the remaining 7.5 ns.
However, there is a sharp drop in RMSD to around 1.6
Å after 4 ns, before a return to oscillation around 1.9 Å
over the rest of the trajectory. Even here though, occa-
sional structures are observed to have small RMSD val-
ues: the possible structural origin of this is discussed in
more detail below. Further evidence for equilibration is
provided by the calculated radius of gyration, Rg, which
falls from its initial value of around 7 Å to reach a stable
oscillation about 6.6 Å within 2.5 ns (Figure 4(b)).
(A)
(B)
Figure 4. (a) RMSD and; (b) Rg over 10 ns LFMD trajectory.
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To examine the validity of structures generated
through LFMD simulations, three snapshots were
extracted from the trajectory at 5, 7.5 and 10 ns, and
optimised with LFMM, PM7 and DFT methods. As with
the smaller models above, Cu–N and Cu–O bond lengths
from LFMM and B3LYP-D2 agree within 0.1 Å, and
most angles around Cu to within 1°. An exception is the
pseudo-trans O(Ala2)-Cu-N(His14), which is predicted to
be 177° with LFMM but 164° with DFT.
The RMSD between the three LFMM optimised
snapshots and the structures re-optimised using the meth-
ods above are reported in Table 1. This shows that PM7
and all DFT methods tested are in good agreement with
LFMM. Notably, DFT methods that explicitly account
for non-covalent interactions generally show better agree-
ment, with B3LYP giving the largest RMSD values,
while B3LYP-D2 is the DFT method that gives struc-
tures most comparable to LFMM. Heavy atom RMSD
values are slightly smaller than those for all atoms. Fur-
ther analysis (Tables S4 and S5 in the supporting infor-
mation) shows that non-coordinated residues make a
larger contribution to the overall RMSD than do Cu and
coordinated residues (0.36/0.22, 0.61/0.43 and 0.52/0.36
Å for non-coordinated/coordinated residues in snapshots
1, 2 and 3, respectively), such that the minor differences
observed are apparently due to mismatches between
AMBER and B3LYP-D2 for the peptide, rather than the
effects of Cu-coordination. Despite some variance
between the methods, RMSD values indicate good agree-
ment against structures calculated using the copper
LFMM parameters. This is particularly evident for the
systems truncated to include only the copper and coordi-
nating residues, showing very good agreement between
DFT and LFMM optimised coordination spheres.
PM7 gives excellent agreement against LFMM opti-
mised structures with very small RMSD values across all
three snapshots and the corresponding atom subsets. To
validate these results the PM7 optimised structures have
been compared against the DFT optimised structures,
with RMSD values reported in Table S7 in the support-
ing information. In general, the difference between the
structures is very good with RMSD values ranging from
0.30 to 0.59 Å against B3LYP-D2. This performance of
PM7 led us to use this method on further snapshots; a
total of 21 snapshots, including snapshots 1, 2 and 3;
were collected from the simulation at regular intervals of
0.25 ns starting at 5 ns. RMSD between LFMM and
PM7 optimised structures averages 0.20 Å (maximum
value = 1.37 Å, minimum = 0.08 Å). The difference
between the two methods here is found to be small with
very little rearrangement of the LFMM systems when
using the semi-empirical method, showing that for this
case the LFMM parameters perform very well compared
to PM7.
As noted above, RMSD from the starting point indi-
cates that equilibration is reached in approximately 5 ns,
but than even beyond this point variations exist. To
probe the signiﬁcance of these, a range of geometrical
parameters were calculated and their variation over the
second half of the trajectory analysed. The resulting val-
ues are summarised in Table 2, indicating that most vary
only slightly around average values, with standard devia-
tions close to 0.1 Å. The obvious exception to this pat-
tern is the ‘ﬂoating’ contact between Cu and O from the
backbone carbonyl of ASP1, which exhibits a larger
standard deviation and a much greater spread between
minimum and maximum values. As shown in Figure 5,
for the bulk of the 5 ns recorded this distance stays
between 2.5 and 3.0 Å, but repeatedly increases to
around 4.5 Å. This indicates that O1 can act as a possi-
ble ﬁfth ligand, albeit weakly, but that an alternate form
with no such weak coordination is also sampled during
the LFMD trajectory. A histogram of the same data
shows that O1 never comes closer than 2.30 Å to Cu,
but spends over 95% of the trajectory within 3.0 Å.
Table 1. RMSD values between LFMM optimised structures and further optimisations using a variety of methods. Values in
parenthesis are RMSD values with hydrogens excluded.
Method RMSD of 1 (Å) RMSD of 2 (Å) RMSD of 3 (Å)
PM7 0.13 (0.13) 0.18 (0.18) 0.27 (0.26)
B3LYP 0.50 (0.46) 0.71 (0.63) 0.54 (0.49)
B3LYP-D2 0.33 (0.31) 0.59 (0.52) 0.48 (0.44)
BHandH 0.39 (0.36) 0.55 (0.50) 0.54 (0.50)
M06-2X 0.43 (0.39) 0.73 (0.66) 0.51 (0.47)
Table 2. Selected geometrical parameters, averaged over ﬁnal
5 ns of LFMD trajectory (Å and °).
Ave SD Min Max
Cu–O2* 2.116 0.118 1.723 2.579
Cu–N6 2.118 0.066 1.911 2.428
Cu–N13 2.132 0.067 1.904 2.399
Cu–N14 2.109 0.061 1.897 2.344
Cu⋯O1 2.678 0.230 2.316 4.584
N6–Cu–N13 170.4 4.2 154.2 179.8
O2–Cu–N14 171.9 4.3 152.6 179.9
Rg 6.604 0.044 6.475 6.760
*Numbers after oxygen and nitrogen ligands relate to their coordinating
residues.
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It should also be reiterated that the molecular dynamics
simulation was carried out with implicit solvation; in the
case of explicit solvation a neutral water molecule might
act as a weakly coordinated ﬁfth ligand instead of the
carbonyl moiety observed here.
Transient coordination modes, such as Cu...O1, were
previously proposed by Raffa and Rauk (2007) although
the apical ligands in their study were carboxylates from
ASP and GLU residues. Coordination of oxygen from
ASP1 is also observed in ‘component I’ species of cop-
per Aβ, found at slightly acidic pH (Dorlet et al., 2009;
Drew et al., 2009). Figure 6 shows two snapshots from
the LFMD trajectory with short and long Cu⋯O1 inter-
actions, truncated to the coordination sphere. Within this
implementation of LFMM there is no possibility for
ligand exchange, such that associative ligand exchange
reactions, for instance of ALA2 by ASP1, cannot be
modelled.
Table 2 reports Rg over the ﬁnal 5 ns of simulation.
The average value of 6.6 Å, with a very small standard
deviation of 0.04 Å, indicates a relatively compact struc-
ture. A low mode molecular dynamics conformational
search of free Aβ1–16 was carried out resulting in an
average Rg of 7.2 Å. This larger value shows, as would
(A)
(B)
Figure 5. (a) Cu⋯O1 distances values for snapshots taken every 0.001 ns; (b) histogram of Cu...O1 interaction distance.
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be expected, that the geometrical constraints arising from
copper coordination lead to a slightly more compact pep-
tide conformation on average.
Conclusions
A deeper understanding of copper’s role within Aβ pep-
tides and its signiﬁcance in the progression of Alzhei-
mer’s disease is of great importance. Experimental
studies have broached this, alongside extensive computa-
tional simulations but much is still unknown. A potential
tool for this application is LFMM, which has already
proven successful in calculations on copper containing
proteins (Deeth, 2007; Diedrich & Deeth, 2008). It offers
greater transferability than inclusion of ad hoc copper
parameters within force ﬁelds and is much less computa-
tionally expensive than ab initio molecular dynamics,
whilst still producing results of close to DFT accuracy
(Cendic, Matovic, & Deeth, 2013).
We have tested copper LFMM parameters on a set of
small molecule test systems with imidazole and for-
mamide representing, N binding from histidine and back-
bone carbonyl coordination, respectively. Errors between
angle and bond lengths of DFT and LFMM optimisa-
tions were found to be small, typically less than 0.1 Å
or 5°. These parameters were then utilised in LFMD
simulations of Cu–Aβ1–16 with several snapshots
extracted from the trajectory for further analysis. Optimi-
sations of the snapshots using several DFT methods and
PM7 resulted in good agreement against LFMM geome-
tries. In particular, PM7 showed excellent results with
very small RMSD values compared to the LFMM
geometry.
Analysis of the LFMD trajectory showed that copper
bond lengths and angles remained stable throughout the
simulation, with small deviations away from average val-
ues. A possible ﬁfth coordination mode was also
observed, with the carbonyl group from the ASP1 resi-
due acting as a transient ligand. Penta-coordinate Aβ
copper systems have been previously observed in simula-
tions, but usually attributed to carboxylate groups on
ASP and GLU residues, (Dorlet et al., 2009; Hureau
et al., 2009; Raffa & Rauk, 2007) whilst this binding
mode is more representative of the component I model
of Cu–Aβ.
The overall strong performance of LFMM for copper
bound to Aβ here shows that there is great potential in
this technique. With good agreement between LFMM
and DFT/PM7 geometries for not only test structures but
also the Aβ1–16 peptide, it shows that these parameters
should be applicable to larger Aβ fragments as well the
full 42 residue peptide and to dimers and beyond.
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